fluconazole has been researched along with griseofulvin in 87 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (20.69) | 18.2507 |
2000's | 37 (42.53) | 29.6817 |
2010's | 24 (27.59) | 24.3611 |
2020's | 8 (9.20) | 2.80 |
Authors | Studies |
---|---|
Cortijo, J; Gálvez, J; García-Domenech, R; Morcillo, E; Ríos-Santamarina, I; Santamaria, P | 1 |
Duffy, EM; Jorgensen, WL | 1 |
Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Brien, JF; Dercho, RA; Kinobe, RT; Nakatsu, K; Szarek, WA; Vlahakis, JZ | 1 |
Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Ahmad, A; Khan, AU; Musthafa, TN; Siddiqui, ZN | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ; Teraiya, SB | 1 |
Bizzarri, B; Bolasco, A; Carradori, S; D'Ascenzio, M; Mari, E; Polletta, L; Rivanera, D; Secci, D; Zicari, A | 1 |
Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ | 1 |
Ishar, MP; Kaur, H; Saxena, AK; Sharma, V; Singh, G | 1 |
Bizzarri, B; Bolasco, A; Carradori, S; Lotti, LV; Mari, E; Rivanera, D; Secci, D; Zicari, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Wang, SQ; Wang, YF; Xu, Z | 1 |
Gao, F; Huang, G; Wang, T; Xiao, J | 1 |
Gao, F; Huang, G; Xiao, J | 1 |
Wenig, JA | 1 |
DeDoncker, PR; Degreef, HJ | 1 |
Roberts, DT | 1 |
Bickers, DR | 1 |
Sangueza, OP; Shupack, JL; Stiller, MJ | 1 |
Hay, RJ | 1 |
Faergemann, J; Laufen, H | 1 |
Faergemann, J; Haglund, A; Mörk, NJ; Odegård, T | 1 |
Haberreiter, A; Paule, I; Seidl, HP; Wildfeuer, A | 1 |
Seebacher, C | 2 |
Friedlander, SF; Suarez, S | 1 |
Frieden, IJ; Howard, RM | 1 |
Tanuma, H | 1 |
Faergemann, J | 1 |
Gupta, AK; Lambert, J | 1 |
Gupta, AK; Shear, NH | 1 |
Korting, HC; Niewerth, M | 1 |
Nagino, K; Ogawa, M; Shimohira, H; Uchida, K; Yamaguchi, H | 1 |
Bradley, MC; Elewski, BE; Ghannoum, MA; Isham, N; Leidich, S | 1 |
Del Rosso, JQ; Gupta, AK | 1 |
Gupta, AK; Summerbell, RC | 1 |
Gupta, AK | 1 |
Gregurek-Novak, T; Gupta, AK | 1 |
Chen, BK; Friedlander, SF | 1 |
Fukuda, T | 1 |
Abeck, D; Korting, HC; Möhrenschlager, M; Ring, J; Seidl, HP | 1 |
Engelen, M; Rochette, F; Vanden Bossche, H | 1 |
Bigby, M | 1 |
Gupta, AK; Ryder, JE | 1 |
Nabeshima, T; Sekiguchi, K; Sobue, S | 1 |
Fernandez-Obregon, AC; Greer, DL; Wignall, FS; Wingfield, AB | 1 |
Reinel, D | 1 |
Chan, YC; Friedlander, SF | 1 |
Gupta, AK; Johnson, AM; Ryder, JE | 1 |
Friedlander, SF; Roberts, BJ | 1 |
Azizzadeh, M; Dastghaib, L; Jafari, P | 1 |
Elewski, BE; Foster, KW; Friedlander, SF; Ghannoum, MA; Panzer, H | 1 |
Hector, RF | 1 |
Crawford, F; Ferrari, J | 2 |
Ghannoum, M; Isham, N; Sheehan, D | 1 |
Tietz, HJ | 1 |
Alvarez, MS; Silverberg, NB | 1 |
Barros, ME; Hamdan, JS; Santos, Dde A | 1 |
Cursino-Santos, JR; Martinez-Rossi, NM; Paião, FG; Peres, NT; Segato, F | 1 |
Ali, S; Forgie, SE; Graham, TA | 1 |
Bergus, G; González, U; Jacobson, J; Martínez-Monzón, C; Seaton, T | 1 |
Millikan, LE | 1 |
Amitai, Z; Kaliner, E; Kopel, E; Predescu, S; Sprecher, H; Volovik, I | 1 |
Arora, P; Grover, C; Manchanda, V | 1 |
Alexis, A; Bhanusali, D; Coley, M; Silverberg, JI; Silverberg, NB | 1 |
Amichai, B; Davidovici, B; Grunwald, MH; Magun, R; Plotnik, IB; Shemer, A | 1 |
Bennett, C; Chen, X; González, U; Hua, X; Jiang, X; Lin, X; Xue, S; Yang, M; Zhang, M | 1 |
Blanck, J; Cohen, B; Kwatra, SG; Zampella, JG | 1 |
Dev, T; Saginatham, H; Sethuraman, G | 1 |
Friedlander, SF; Gupta, AK; Mays, RR; Piguet, V; Piraccini, BM; Shear, NH; Tosti, A; Versteeg, SG | 1 |
Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M | 1 |
Anchan, VN; Chandra, U; Singh, S; Tilak, R; Verma, P | 1 |
Elewski, B | 1 |
Mathachan, SR; Sardana, K | 1 |
Cohen, BA; DiBiagio, JR; Goldenberg, NA; Le, TK; Woodard, AA | 1 |
Azrad, M; Kassem, R; Nitzan, O; Peretz, A; Shemesh, Y | 1 |
Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A | 1 |
Amin Shahidi, M; Badiee, P; Ghasemi, F; Hashemi, J; Jafarian, H; Mohammadi, R; Najafzadeh, MJ; Shokohi, T | 1 |
35 review(s) available for fluconazole and griseofulvin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Tetrazole hybrids and their antifungal activities.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Mycoses; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tetrazoles | 2019 |
Antibacterial activity study of 1,2,4-triazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
The systemic treatment of onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1995 |
Current therapy of dermatophytosis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Dermatomycoses; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Morpholines; Time Factors; Tolnaftate | 1994 |
Oral therapeutic agents in fungal nail disease.
Topics: Administration, Oral; Allylamine; Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Time Factors; Treatment Outcome | 1994 |
Antifungal therapy: potential interactions with other classes of drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Griseofulvin; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
Systemic drugs in the treatment of dermatophytoses.
Topics: Antifungal Agents; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Molecular Structure | 1993 |
Onychomycosis. Agents of choice.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Candidiasis, Cutaneous; Fluconazole; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1993 |
[Diagnosis, differential diagnosis and therapy of onychomycosis].
Topics: Administration, Topical; Antifungal Agents; Diagnosis, Differential; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
Pediatric antifungal therapy.
Topics: Antifungal Agents; Child; Dermatomycoses; Drug Interactions; Female; Fluconazole; Griseofulvin; Humans; Itraconazole; Male; Naphthalenes; Terbinafine | 1998 |
Dermatophyte infections in children.
Topics: Antifungal Agents; Arthrodermataceae; Child; Child, Preschool; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microsporum; Naphthalenes; Terbinafine; Tinea; Trichophyton | 1999 |
Current topics in diagnosis and treatment of tinea unguium in Japan.
Topics: Administration, Oral; Aged; Antifungal Agents; Diagnosis, Differential; Female; Fluconazole; Griseofulvin; Humans; Itraconazole; Japan; Male; Onychomycosis | 1999 |
Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA.
Topics: Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; United States | 1999 |
The new oral antifungal agents for onychomycosis of the toenails.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1999 |
An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
Tinea capitis.
Topics: Antifungal Agents; Arthrodermataceae; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Scalp; Terbinafine; Tinea Capitis | 2000 |
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Arthrodermataceae; Ciclopirox; Costs and Cost Analysis; Drug Costs; Economics, Pharmaceutical; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Models, Economic; Naphthalenes; Onychomycosis; Pyridones; Randomized Controlled Trials as Topic; Terbinafine; United States | 2000 |
Tinea capitis update: a continuing conflict with an old adversary.
Topics: Antifungal Agents; Child; Child, Preschool; Drug Interactions; Drug Resistance, Fungal; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis; United States | 2001 |
[Tinea capitis. Therapeutic options in the post-griseofulvin era].
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Interactions; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis; Treatment Outcome | 2002 |
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs | 2003 |
The use of oral antifungal agents to treat onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Drug Interactions; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2003 |
New treatments for tinea capitis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Microsporum; Naphthalenes; Terbinafine; Tinea Capitis; Trichophyton | 2004 |
Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Randomized Controlled Trials as Topic; Terbinafine; Treatment Outcome | 2004 |
Tinea capitis: a treatment update.
Topics: Antifungal Agents; Child; Dose-Response Relationship, Drug; Fluconazole; Griseofulvin; Humans; Itraconazole; Microsporum; Naphthalenes; Pediatrics; Terbinafine; Tinea Capitis; Treatment Outcome; Trichophyton | 2005 |
An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; Griseofulvin; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Severity of Illness Index | 2005 |
Fungal nail infections.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2005 |
Fungal toenail infections.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2006 |
Tinea capitis.
Topics: Antifungal Agents; Fluconazole; Global Health; Griseofulvin; Humans; Itraconazole; Microsporum; Naphthalenes; Terbinafine; Tinea Capitis; Trichosporon; United States | 2006 |
The assessment and management of tinea capitis in children.
Topics: Antifungal Agents; Child; Diagnosis, Differential; Fluconazole; Griseofulvin; Humans; Incidence; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis | 2007 |
Systemic antifungal therapy for tinea capitis in children.
Topics: Antifungal Agents; Child; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Randomized Controlled Trials as Topic; Terbinafine; Tinea Capitis | 2007 |
Systemic antifungal therapy for tinea capitis in children.
Topics: Antifungal Agents; Child; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Randomized Controlled Trials as Topic; Terbinafine; Tinea Capitis | 2016 |
Tinea in Tots: Cases and Literature Review of Oral Antifungal Treatment of Tinea Capitis in Children under 2 Years of Age.
Topics: Administration, Oral; Antifungal Agents; Drug Administration Schedule; Female; Fluconazole; Griseofulvin; Humans; Infant; Infant, Newborn; Male; Tinea Capitis | 2017 |
Tinea capitis in children: a systematic review of management.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Child; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microsporum; Specimen Handling; Terbinafine; Tinea Capitis; Trichophyton | 2018 |
10 trial(s) available for fluconazole and griseofulvin
Article | Year |
---|---|
Levels of fluconazole in normal and diseased nails during and after treatment of onychomycoses in toe-nails with fluconazole 150 mg once weekly.
Topics: Antifungal Agents; Double-Blind Method; Fluconazole; Griseofulvin; Humans; Nails; Onychomycosis; Time Factors | 1996 |
A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Fluconazole; Griseofulvin; Humans; Male; Middle Aged; Tinea | 1997 |
Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Terbinafine; Trichophyton | 1999 |
Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Follow-Up Studies; Foot Dermatoses; Gastrointestinal Diseases; Griseofulvin; Humans; Itraconazole; Male; Middle Aged; Mitosporic Fungi; Naphthalenes; Nausea; Onychomycosis; Photosensitivity Disorders; Prospective Studies; Single-Blind Method; Terbinafine; Treatment Outcome; Vomiting | 2001 |
Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Female; Fluconazole; Griseofulvin; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Prospective Studies; Skin; Terbinafine; Tinea; Treatment Outcome | 2004 |
Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Chi-Square Distribution; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Fluconazole; Griseofulvin; Humans; Infant; Male; Prospective Studies; Severity of Illness Index; Statistics, Nonparametric; Tinea Capitis; Treatment Outcome | 2005 |
A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis.
Topics: Antifungal Agents; Child; Child, Preschool; Female; Fluconazole; Griseofulvin; Humans; Male; Single-Blind Method; Tinea Capitis; Treatment Outcome | 2005 |
Comparative evaluation of griseofulvin, terbinafine and fluconazole in the treatment of tinea capitis.
Topics: Antifungal Agents; Child; Cross-Sectional Studies; Female; Fluconazole; Griseofulvin; Humans; Male; Naphthalenes; Terbinafine; Tinea Capitis; Trichophyton | 2012 |
Treatment of tinea capitis - griseofulvin versus fluconazole - a comparative study.
Topics: Antifungal Agents; Child; Child, Preschool; Female; Fluconazole; Griseofulvin; Humans; Infant; Israel; Male; Prevalence; Risk Assessment; Tinea Capitis | 2013 |
Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.
Topics: Antifungal Agents; Epidemics; Fluconazole; Griseofulvin; Humans; India; Itraconazole; Naphthalenes; Pharmaceutical Preparations; Terbinafine; Tinea | 2020 |
42 other study(ies) available for fluconazole and griseofulvin
Article | Year |
---|---|
New bronchodilators selected by molecular topology.
Topics: Animals; Bronchodilator Agents; Discriminant Analysis; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Structure-Activity Relationship; Trachea | 1998 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
ElogPoct: a tool for lipophilicity determination in drug discovery.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Inhibition of the enzymatic activity of heme oxygenases by azole-based antifungal drugs.
Topics: Animals; Antifungal Agents; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Ketoconazole; Kinetics; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley | 2006 |
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Thermal solvent-free synthesis of novel pyrazolyl chalcones and pyrazolines as potential antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Chalcones; Fungi; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Solvents; Temperature | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
An efficient one-pot synthesis, structure, antimicrobial and antioxidant investigations of some novel quinolyldibenzo[b,e][1,4]diazepinones.
Topics: Anti-Infective Agents; Antioxidants; Azepines; Crystallography, X-Ray; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Conformation; Quinolines | 2012 |
Synthesis, anti-Candida activity, and cytotoxicity of new (4-(4-iodophenyl)thiazol-2-yl)hydrazine derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Candida; Cell Survival; Chemistry Techniques, Synthetic; Hep G2 Cells; Humans; Hydrazines; Microbial Sensitivity Tests | 2012 |
An improved microwave assisted one-pot synthesis, and biological investigations of some novel aryldiazenyl chromeno fused pyrrolidines.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Azo Compounds; Benzopyrans; Candida albicans; Crystallography, X-Ray; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Stereoisomerism; Thiosemicarbazones | 2012 |
Synthesis of β-ionone derived chalcones as potent antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Chalcones; Fungi; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycoses; Norisoprenoids; Staphylococcal Infections | 2012 |
Synthesis and cytotoxicity of novel (thiazol-2-yl)hydrazine derivatives as promising anti-Candida agents.
Topics: Antifungal Agents; Candida; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Hydrazines; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiazoles | 2013 |
In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Culture Media; Fluconazole; Fungi; Griseofulvin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts | 1997 |
Pharmacokinetics of fluconazole in skin and nails.
Topics: Administration, Oral; Adult; Antifungal Agents; Fluconazole; Griseofulvin; Humans; Male; Nails; Onychomycosis; Skin; Sweat | 1999 |
The use of systemic antimycotics in dermatotherapy.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Dermatomycoses; Fluconazole; Griseofulvin; Hair Diseases; Humans; Itraconazole; Ketoconazole; Naphthalenes; Odds Ratio; Onychomycosis; Terbinafine; Tinea | 2000 |
Comparison of the therapeutic efficacy of oral doses of fluconazole and griseofulvin in a guinea pig model of dermatophytosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Dermatomycoses; Disease Models, Animal; Female; Fluconazole; Griseofulvin; Guinea Pigs; Tinea; Treatment Outcome | 2000 |
[Diversified treatments of Tinea unguium].
Topics: Administration, Oral; Antifungal Agents; Combined Modality Therapy; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Occlusive Dressings; Onychomycosis; Pulse Therapy, Drug; Terbinafine | 2002 |
Newer antifungal agents.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Naphthalenes; Terbinafine; Tinea Capitis | 2003 |
Intracutaneous distributions of fluconazole, itraconazole, and griseofulvin in Guinea pigs and binding to human stratum corneum.
Topics: Administration, Topical; Animals; Antifungal Agents; Area Under Curve; Fluconazole; Griseofulvin; Guinea Pigs; Half-Life; Humans; In Vitro Techniques; Itraconazole; Keratins; Nails; Skin | 2004 |
[Onychomycosis].
Topics: Antifungal Agents; Ciclopirox; Debridement; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Morpholines; Mycological Typing Techniques; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Time Factors | 2004 |
[Modern antimycotics. What the treating physician needs to know].
Topics: Antifungal Agents; Arthrodermataceae; Child; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Time Factors | 2004 |
Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial.
Topics: Antifungal Agents; Arthrodermataceae; Clinical Trials as Topic; Fluconazole; Griseofulvin; Humans; Microbial Sensitivity Tests; Pyrimidines; Tinea Capitis; Triazoles; Voriconazole | 2006 |
[Current treatment recommendations in tinea corporis?].
Topics: Antifungal Agents; Clotrimazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea | 2006 |
In vitro methods for antifungal susceptibility testing of Trichophyton spp.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine; Trichophyton | 2006 |
Analysis of Trichophyton rubrum gene expression in response to cytotoxic drugs.
Topics: Antifungal Agents; Blotting, Northern; DNA, Complementary; Expressed Sequence Tags; Fatty Acids; Fluconazole; Gene Expression Regulation, Fungal; Genes, Fungal; Griseofulvin; Molecular Sequence Data; Naphthalenes; Nucleic Acid Hybridization; Sequence Analysis, DNA; Terbinafine; Trichophyton | 2007 |
Current concepts in systemic and topical therapy for superficial mycoses.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Antifungal Agents; Azoles; Dermatomycoses; Drug Administration Schedule; Drug Resistance, Fungal; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Morpholines; Tolnaftate; United States | 2010 |
Tinea capitis outbreak in a paediatric refugee population, Tel Aviv, Israel.
Topics: Antifungal Agents; Child; Child, Preschool; Disease Outbreaks; Female; Fluconazole; Griseofulvin; Humans; Israel; Male; Microsporum; Mycological Typing Techniques; Naphthalenes; RNA, Ribosomal, 28S; Terbinafine; Tinea Capitis | 2012 |
Treatment outcomes for tinea capitis in a skin of color population.
Topics: Adolescent; Age Factors; Antifungal Agents; Black or African American; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Fluconazole; Follow-Up Studies; Griseofulvin; Hispanic or Latino; Humans; Infant; Itraconazole; Male; Naphthalenes; New York City; Retrospective Studies; Terbinafine; Tinea Capitis; Treatment Outcome; Urban Population; White People | 2012 |
Tinea Faciei: Challenges in the Diagnosis.
Topics: Administration, Oral; Antifungal Agents; Child, Preschool; Facial Dermatoses; Fluconazole; Griseofulvin; Humans; Male; Prognosis; Recurrence; Retreatment; Risk Assessment; Severity of Illness Index; Tinea; Treatment Outcome | 2017 |
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Tinea Pedis; Triazoles; Trichophyton; Voriconazole | 2020 |
A call for antifungal stewardship.
Topics: Antifungal Agents; Epidemics; Fluconazole; Griseofulvin; Humans; India; Itraconazole; Pharmaceutical Preparations; Terbinafine; Tinea | 2020 |
The science and rationale of arriving at the correct drug and dosimetry of griseofulvin, fluconazole, terbinafine and itraconazole in superficial dermatophyte infections: an important step before a pragmatic trial.
Topics: Antifungal Agents; Arthrodermataceae; Epidemics; Fluconazole; Griseofulvin; Humans; India; Itraconazole; Pharmaceutical Preparations; Terbinafine | 2021 |
A Retrospective Study of Tinea Capitis Management in General Pediatric Clinics and Pediatric Emergency Departments at 2 US Centers.
Topics: Academic Medical Centers; Adolescent; Antifungal Agents; Child; Child, Preschool; Cross-Sectional Studies; Emergency Service, Hospital; Female; Fluconazole; Griseofulvin; Humans; Male; Pediatrics; Practice Patterns, Physicians'; Retrospective Studies; Terbinafine; Tinea Capitis; United States | 2021 |
Tinea capitis in an immigrant pediatric community; a clinical signs-based treatment approach.
Topics: Antifungal Agents; Child; Emigrants and Immigrants; Fluconazole; Griseofulvin; Humans; Tinea Capitis | 2021 |
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole | 2022 |
Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study.
Topics: Antifungal Agents; Arthrodermataceae; Caspofungin; Fluconazole; Griseofulvin; Hospitals, University; Humans; Iran; Itraconazole; Terbinafine; Triazoles | 2023 |